Related Experiment Videos
Current perspectives on Kawasaki disease
Monesha Gupta-Malhotra1, P Syamasundar Rao
1University of Texas Houston Medical School & Memorial Hermann Children's Hospital, Houston, Texas, USA. Monesha.gupta@uth.tmc.edu
Insights
Kawasaki disease (KD) etiology is unknown, but recent research implicates coronavirus and genetics. Diagnosis has evolved with new criteria for incomplete KD, while treatment challenges remain for immunoglobulin-resistant cases.
Area of Science:
- Pediatrics
- Rheumatology
- Infectious Diseases
Background:
- Kawasaki disease (KD) etiology remains elusive, with recent focus on coronavirus infection and genetic factors.
- Diagnostic criteria for KD have seen minor updates, including revised fever duration and new criteria for incomplete and atypical forms.
- Long-term outcomes and treatment strategies for KD, particularly for immunoglobulin-resistant cases, are areas of ongoing investigation.
Purpose of the Study:
- To review the current understanding of Kawasaki disease etiology and diagnostic criteria.
- To discuss treatment approaches for Kawasaki disease, including challenges in immunoglobulin-resistant cases.
- To highlight recent findings on long-term outcomes and potential risks like premature atherosclerosis.
Main Methods:
- Literature review of recent research on Kawasaki disease etiology.
- Analysis of updated diagnostic criteria, including echocardiography and laboratory findings.
- Summary of treatment modalities and outcomes for typical and resistant KD cases.
Main Results:
- Etiology of Kawasaki disease is still unknown, with emerging links to coronavirus and genetic polymorphisms.
- Updated diagnostic criteria now include specific criteria for incomplete Kawasaki disease.
- Long-term follow-up data reveal concerns about increased risk of premature atherosclerosis in childhood KD survivors with coronary abnormalities.
Conclusions:
- Kawasaki disease diagnosis and management continue to evolve, with ongoing research into its causes.
- Effective treatment strategies for immunoglobulin-resistant Kawasaki disease are crucial.
- Long-term surveillance for cardiovascular complications in Kawasaki disease patients is essential.
Abstract:
The etiology of Kawasaki disease (KD) remains unknown despite several years of dedicated research in this direction. Recently coronavirus infection and genetic polymorphisms have been implicated. Since first description of the disease there have been few changes in the diagnostic criteria except for newer recommendations of fever of at least 4 instead of 5 days duration. Recently, Echocardiography Criteria and Laboratory Criteria have been added to aid in the diagnosis of incomplete KD where all the historical diagnostic criteria are not present; this is now called the "incomplete form of KD" as opposed to "atypical form of KD". The word "atypical" is reserved for unusual presentations of KD such as those with hemophagocytic syndrome or nerve palsy. The treatment of KD includes infusion of high dose immunoglobulin. Patients non-responsive to immunoglobulin therapy are labeled as having "immunoglobulin resistant KD". The treatment of immunoglobulin resistant KD can be challenging and new therapies that have tried with some success. Late outcomes after 4 decades of treating these patients have recently been published. There has been some concern about increased risk for premature atherosclerosis in patients with childhood KD who had coronary artery abnormalities.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Myocarditis I: Introduction
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Kidney Disease II: Clinical Manifestations